06/11/2026
T-cells are the immune system’s frontline defenders with a crucial role in controlling HIV. In a milestone clinical trial published in the Journal of Clinical Investigation, researchers with the UNC Institute for Global Health and Infectious Diseases (IGHID) at the UNC School of Medicine have demonstrated that new vaccines can significantly boost T cells targeting the most vulnerable, conserved regions of HIV—areas considered key to effective immune control. This pivotal finding not only advances our understanding of HIV immunology but also offers hope that these vaccines could contribute to novel, curative approaches against HIV.
Read more here: https://globalhealth.unc.edu/2026/06/supercharging-t-cells-against-hivs-weak-spots-a-new-hiv-vaccine-study-reveals-new-hope-and-new-challenges-for-aging-patients/